Litton, J. K.
Scoggins, M.
Ramirez, D. L.
Murthy, R. K.
Whitman, G. J.
Hess, K. R.
Adrada, B. E.
Moulder, S. L.
Barcenas, C. H.
Valero, V.
Gomez, J. Schwartz
Mittendorf, E. A.
Thompson, A.
Helgason, T.
Mills, G. B.
Piwnica-Worms, H.
Arun, B. K.
Article History
Received: 11 April 2017
Revised: 3 November 2017
Accepted: 20 November 2017
First Online: 6 December 2017
Competing interests
: Dr. Litton has clinical research to her Institution with Medivation/Pfizer, Astra-Zeneca, Genentech, Glaxo-Smith Kline, Novartis and served on Trial Steering Committees with Medivation/Pfizer and Novartis. Dr. Arun has clinical research with AbbVie and serves on a Trial Steering Committee for AbbVie. Gary Whitman owns stock in Pfizer, which is disclosed and within the limits of the MD Anderson conflict of interest policy. The remaining authors declare no competing financial interests.